Bevacizumab plus chemotherapy vs chemotherapy alone
Economic evaluation · women with persistent, recurrent, or metastatic cervical cancer
1 finding from 1 review
- Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 452 participantsLow